The next day at the Galaxy Securities headquarters in Beijing.
"Mr. Li, there's a large short-selling operation in one account that needs your review."
"Three billion?" The well-dressed Mr. Li glanced at the document, his expression unchanged.
After all, he was experienced; to him, this sum of money wasn't particularly immense.
However, the client had left almost no margin and had shorted a large volume of the same stock, which was quite intriguing.
But when he saw the specific stock the funds were being used to operate on, he paused for a moment, then a hint of a smile curved at the corner of his mouth.
"Chang Chun Biological? Heh, interesting."
The stock price of Chang Chun Biological had recently been hitting record highs and was now the high-priced stock second only to Kweichow Moutai in the A-shares market.